PRNewsWire · 1672.HK · October 19, 2026

Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity

Get the app for more

Explore stock news, insights and company research.